Decrease the text size Increase the text size Print this page

Archived behind the news articles

Related information

Community Q&A

Behind-the-news articles are published in response to issues that are of interest to the community at a point in time, for example, subjects that have been in the media.

2020

Information for clinicians on ventilators and alternative strategies when in short supply during COVID-19

17 April 2020

The TGA has been involved in exploring ways to further increase supply of ventilators when and where they are needed

2014

Trasylol

14 October 2014

The TGA is aware of a recent media report about fatal adverse events associated with Trasylol
Results of review into urogynaecological surgical mesh implants

20 August 2014

The TGA has completed a review of urogynaecological surgical mesh implants
Liquid nicotine and personal importation for use in electronic cigarettes

4 June 2014

Some recent media reports about electronic cigarettes suggest that the importation of nicotine in personal amounts is exempt from regulation
Review into urogynaecological surgical mesh implants

28 May 2014

The TGA has completed a review into urogynaecological surgical mesh implants as a class of products
Complementary medicines - compliance reviews 2013

4 April 2014

More than 1600 new complementary medicines are listed each year

2013

Listed medicines: The role of Australia's medicines regulator

27 June 2013

Different types of medicines are regulated in different ways by the TGA, depending on what they contain and how they are to be used

2012

Cough and cold medicines for children - changes

26 November 2012

This TGA behind-the-news article was published on 26 November 2012. Behind the news articles are published in response to issues that are …
Concerns with urogynaecological surgical mesh implants

16 October 2012

The TGA continues to monitor the rate of complications with surgical mesh
Urogynaecological surgical mesh implants - statement provided to the 7.30 Report (ABC) by the TGA

15 October 2012

Statement provided by the TGA to the 7.30 Report (ABC) about urogynaecological surgical mesh implants
Registration of Mifepristone Linepharma (RU 486) and GyMiso (misoprostol)

30 August 2012

Mifepristone Linepharma and GyMiso have been registered TGA for wider use in Australia
Interpreting information on the Database of Adverse Event Notifications

3 August 2012

The TGA is concerned by a media story that may mislead consumers and could potentially discourage them from receiving influenza vaccinations
The TGA decision to ban DMAA

3 August 2012

As of 8 August 2012 the use of chemical 1,3-dimethylamylamine (DMAA) is illegal
Why hasn't the TGA taken Stilnox off the market?

6 July 2012

The TGA has been closely monitoring the sleeping drug, zolpidem (Stilnox) for many years

2011

The regulation of medical devices

18 November 2011

Medical devices range from sticking plasters, to high-risk products such as pacemakers
The TGA and the USA FDA agree about problems at CSL Biotherapies

8 July 2011

The TGA wishes to clarify some aspects of this action and what it means for public safety
Evaluation of a new medicine - The TGA's lifecycle approach to regulation

30 June 2011

Before a prescription medicine can be marketed in Australia, the TGA assesses the risks and the benefits from the available evidence
CSL Biotherapies: 'Warning Letter' issued by the United States' Food and Drug Administration

24 June 2011

The TGA routinely audits CSL and is aware of the issues raised by the FDA
Recall of DePuy Orthopaedics ASR hip replacement device

16 May 2011

The ASR hip prosthesis was removed from the Australian market in December 2009 after intervention by the TGA.
Complementary medicines: the regulatory framework

13 May 2011

Australia has a two-tiered system for the regulation of medicines, including complementary medicines

URL:https://www.tga.gov.au/node/882125

Therapeutic Goods Administration (TGA)

Main menu

You are here

Archived behind the news articles

Related information

2020

Information for clinicians on ventilators and alternative strategies when in short supply during COVID-19

2014

Trasylol

Results of review into urogynaecological surgical mesh implants

Liquid nicotine and personal importation for use in electronic cigarettes

Review into urogynaecological surgical mesh implants

Complementary medicines - compliance reviews 2013

2013

Listed medicines: The role of Australia's medicines regulator

2012

Cough and cold medicines for children - changes

Concerns with urogynaecological surgical mesh implants

Urogynaecological surgical mesh implants - statement provided to the 7.30 Report (ABC) by the TGA

Registration of Mifepristone Linepharma (RU 486) and GyMiso (misoprostol)

Interpreting information on the Database of Adverse Event Notifications

The TGA decision to ban DMAA

Why hasn't the TGA taken Stilnox off the market?

2011

The regulation of medical devices

The TGA and the USA FDA agree about problems at CSL Biotherapies

Evaluation of a new medicine - The TGA's lifecycle approach to regulation

CSL Biotherapies: 'Warning Letter' issued by the United States' Food and Drug Administration

Recall of DePuy Orthopaedics ASR hip replacement device

Complementary medicines: the regulatory framework

Sitemap Navigation